Institute for Diabetes and Cancer, Helmholtz Center Munich, Neuherberg, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.
Compr Physiol. 2021 Apr 1;11(2):1759-1783. doi: 10.1002/cphy.c200013.
Discovered almost simultaneously with insulin, glucagon is a pleiotropic hormone with metabolic action that goes far beyond its classical role to increase blood glucose. Albeit best known for its ability to directly act on the liver to increase de novo glucose production and to inhibit glycogen breakdown, glucagon lowers body weight by decreasing food intake and by increasing metabolic rate. Glucagon further promotes lipolysis and lipid oxidation and has positive chronotropic and inotropic effects in the heart. Interestingly, recent decades have witnessed a remarkable renaissance of glucagon's biology with the acknowledgment that glucagon has pharmacological value beyond its classical use as rescue medication to treat severe hypoglycemia. In this article, we summarize the multifaceted nature of glucagon with a special focus on its hepatic action and discuss the pharmacological potential of either agonizing or antagonizing the glucagon receptor for health and disease. © 2021 American Physiological Society. Compr Physiol 11:1759-1783, 2021.
胰高血糖素与胰岛素几乎同时被发现,是一种具有代谢作用的多功能激素,其作用远远超出了其增加血糖的经典作用。尽管胰高血糖素最出名的是其直接作用于肝脏以增加葡萄糖的从头合成并抑制糖原分解的能力,但它通过减少食物摄入和增加代谢率来降低体重。胰高血糖素进一步促进脂肪分解和脂质氧化,并在心脏中具有正性变时性和变力性作用。有趣的是,近几十年来,随着人们认识到胰高血糖素除了作为治疗严重低血糖的抢救药物的经典用途之外,还具有药理学价值,胰高血糖素的生物学特性出现了显著的复兴。本文总结了胰高血糖素的多方面特性,特别关注其肝脏作用,并讨论了激动或拮抗胰高血糖素受体在健康和疾病方面的药理学潜力。© 2021 美国生理学会。《综合生理学》11:1759-1783, 2021。